Piia Vuorela

Piia Vuorela

Auto-generated profile, based on publicly available information

Piia Vuorela

Health and Social Welfare Department, Vantaa, Finland

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 June 2021 in Acta Diabetologica
Verified
Journal Article
Open access
PDF file
MTMikko Tarvonen
Mikko Tarvonen
PHPetteri Hovi
Petteri Hovi
SSSusanna Sainio
Susanna Sainio
PVPiia Vuorela
Piia Vuorela
SASture Andersson
Sture Andersson
KTKari Teramo
Kari Teramo
Aims: In previous reports, cardiotocographic (CTG) fetal heart rate (FHR) monitoring has shown only limited benefits in decreasing adverse perinatal outcomes in pregnancies complicated by gestational diabetes mellitus (GDM). The aim of the present study was to evaluate whether an association exists between the recently reported ZigZag pattern (FHR baseline amplitude changes of > 25 bpm with a duration of 2–30 min) and asphyxia-related neonatal outcomes in GDM pregnancies. Methods: Intrapartal CTGs were recorded in a one-year cohort of 5150 singleton childbirths. The following CTG changes were evaluated: ZigZag pattern, saltatory pattern, late decelerations, episodes of tachycardia and bradycardia, reduced variability, and uterine tachysystole. The cohort was divided into three groups: women with GDM, women with normal oral glucose tolerance test (OGTT), and women with no OGTT performed. Umbilical artery (UA) blood gases, Apgar scores, neonatal respiratory distress, and neonatal encephalopathy were used as outcome variables. Results: GDM was diagnosed in 624 (12.1%), OGTT was normal in 4115 (79.9%), and OGTT was not performed in 411 (8.0%) women. Hypoxia-related ZigZag patterns (OR 1.94, 95% CI 1.64–2.34) and late decelerations (OR 1.65, 95% CI 1.27–2.13) of FHR, as well as a greater risk of fetal asphyxia (UA pH < 7.10 and/or UA BE < -12.0 meq/L and/or Apgar scores < 7 at 5-min) (OR 6.64, 95% CI 1.84–12.03) were observed in those with GDM compared with those without GDM. Conclusions: GDM is associated with intrapartal ZigZag pattern and late decelerations, cord blood acidemia and low 5-min Apgar scores at birth indicating increased occurrence of fetal hypoxia in GDM pregnancies.

1 May 2009 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
PDF file
KWKatja‐Anneli Wathén
Katja‐Anneli Wathén
OYOlavi Ylikorkala
Olavi Ylikorkala
SASture Andersson
Sture Andersson
HAHenrik Alfthan
Henrik Alfthan
USUlf‐Håkan Stenman
Ulf‐Håkan Stenman
PVPiia Vuorela
Piia Vuorela
Objective. Endostatin, an important anti‐angiogenic factor produced by endothelial cells, is elevated in established pre‐eclampsia. We measured maternal serum endostatin concentrations in early pregnancy associated with later pre‐eclampsia and intrauterine growth retardation (IUGR). Design. Retrospective case–control study. Setting. University Central Hospital. Sample. Serum samples were collected at 12–15 and 16–20 gestational weeks from a total of 124 pregnant women of whom 49 developed pre‐eclampsia, 16 gave birth to infants with IUGR without pre‐eclampsia, and 59 remained normotensive giving birth to healthy, normal‐weight infants. Methods. Enzyme‐linked immunosorbent assay. Main outcome measures. Endostatin concentrations in serum. Results. At 12–15 gestational weeks, there was no difference in median endostatin concentrations between the groups. At 16–20 gestational weeks, the median endostatin concentration was higher in the women with subsequent pre‐eclampsia (p = 0.026), especially preceding a later severe form of the disease (p = 0.041), than in the controls. The results were further confirmed by receiver operating characteristic (ROC) analysis showing an area under the curve (AUC) of 0.64 (95% confidence interval: 0.50–0.81) for endostatin to identify subsequent pre‐eclampsia, and 0.71 (0.53–0.89) in cases of severe pre‐eclampsia. Optimal cut‐off values were determined and used for calculations of sensitivity and specificity, which were 80 and 52% (cut‐off value = 58.0 μg/L) in pre‐eclampsia, and 80 and 65% (cut‐off value = 65.5 μg/L) in the severe form of the disease. Conclusions. The concentrations of endostatin in maternal serum at 16–20 weeks’ of gestation are associated with an increased risk of pre‐eclampsia but not IUGR.

1 June 2021 in Journal of Comparative Effectiveness Research
Verified
Journal Article
Closed access
KPKristiina Pynnä
Kristiina Pynnä
PRPirjo Räsänen
Pirjo Räsänen
HSHarri Sintonen
Harri Sintonen
RRRisto P Roine
Risto P Roine
PVPiia Vuorela
Piia Vuorela
Aim: To assess health-related quality of life (HRQoL) of patients with benign gynecological disorders. Materials & methods: Prospective 2-year follow-up with the 15D HRQoL-instrument of 311 women treated in Helsinki-area hospitals in 2012–2013. Results: The initially impaired HRQoL regarding excretion, discomfort and symptoms, and vitality and sexual activity improved after treatment. However, only sexual activity reached similar levels as in the general population. Treatment of endometriosis, fibroids and polyps resulted in best and that of unspecific pelvic pain and bleeding disorders in worst HRQoL scores. Results were independent of hospital size. Conclusion: The impaired HRQoL dimensions were improved by treatment but HRQoL still remained poorer than in the general female population. Treatment of unspecific pelvic pain and bleeding disorders needs further evaluation.

1 July 2008 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
PDF file
KWKatja‐Anneli Wathén
Katja‐Anneli Wathén
LULeila Unkila‐Kallio
Leila Unkila‐Kallio
RIRita Isaksson
Rita Isaksson
ATAila Tiitinen
Aila Tiitinen
USUlf‐Håkan Stenman
Ulf‐Håkan Stenman
PVPiia Vuorela
Piia Vuorela
Objective. To analyze the role of vascular endothelial growth factor (VEGF) and its naturally occurring circulating antagonist, soluble VEGF receptor‐1 (sVEGFR‐1), in infertility. VEGF is a key angiogenic factor in the endometrial and ovarian cyclic processes that are crucial for fertility and sVEGFR‐1 impairs its function and fertility in animals – less is known as regards human fertility. Design. Case–control study. Setting. University Central Hospital, a tertiary referral center. Population. Women with unexplained infertility (n = 15) and fertile controls (n = 10) had serial blood samples collected during their natural cycles, and the infertile women during a subsequent in vitro fertilization (IVF) cycle. Methods. Enzyme‐linked immunosorbent assay was used for this study. Main outcome measures. Concentrations of VEGF and sVEGFR‐1 in the natural cycles and of sVEGFR‐1 during a subsequent IVF cycle. Results. Plasma VEGF concentrations showed no cyclicity in fertile women, but were higher in the infertile group at the midluteal phase. Serum sVEGFR‐1 concentrations were similar between the groups and between natural and IVF cycles. However, in infertile women, concentrations of sVEGFR‐1 increased from the follicular phase to the luteal phase. In the follicular phase infertile women had a high ratio of VEGF/sVEGFR‐1, which was decreased in the luteal phase. Both findings were associated with failure to achieve pregnancy in subsequent IVF cycles. Conclusions. One cause of unexplained infertility may be unbalanced secretion of sVEGFR‐1 with concomitant changes in free VEGF during the transition from the follicular to the luteal phase. This aberration may be related to impaired implantation.

15 May 2012 in Acta Obstetricia et Gynecologica Scandinavica
Verified
Journal Article
Open access
PDF file
EKElina Keikkala
Elina Keikkala
THTimo Hytinantti
Timo Hytinantti
KWKatja‐Anneli Wathén
Katja‐Anneli Wathén
SASture Andersson
Sture Andersson
PVPiia Vuorela
Piia Vuorela
: Objective. To characterize the physiological distribution of angiopoietins (Ang)‐1 and Ang‐2 and soluble endothelial cell‐spesific tyrosine kinase receptor‐2 (Tie‐2) at term and following delivery. Design. A prospective, descriptive study. Setting. Helsinki University Central Hospital. Population. Twenty healthy term pregnant women undergoing elective cesarean delivery and their newborns. Methods. The concentrations were analysed by enzyme‐linked immunosorbent assay in maternal antepartum and the first postpartum day sera, umbilical serum, amniotic fluid and maternal and newborn urine. Main outcome measures. Concentrations of Ang‐1, Ang‐1 and Tie‐2. Results. Concentrations of maternal serum Ang‐1 and Ang‐2 decreased after delivery {[median (range)]: Ang‐1, from 33 (25–51) to 30 (18–49) ng/mL, p= 0.017; and Ang‐2, from 5.4 (1.8–18) to 1.4 (0.7–4.6) ng/mL, p < 0.0001}, whereas Tie‐2 concentrations remained stable [23 (13–41) vs. 25 (14–29) ng/mL, p= 0.107]. Compared with maternal antepartum serum, umbilical serum concentrations of Ang‐1 [46 (28–59) ng/mL, p < 0.0001] and Tie‐2 [45 (21–71) ng/mL, p < 0.0001] were higher and those of Ang‐2 similar [5.4 (1.8–18) vs. 4.2 (2.9–6.0) ng/mL; p= 0.067]. Low concentrations of Ang‐1 [1.2 (0.1–2.2) ng/mL], Ang‐2 [1.1 (0.3–4.1) ng/mL] and Tie‐2 [0.4 (0.08–0.9) ng/mL] were observed in amniotic fluid, but they were undetectable in newborn urine and in most of the maternal urine samples. Conclusions. Maternal Ang‐1 and Ang‐2 concentrations decreased following delivery. Umbilical concentrations of Ang‐1 and Tie‐2 were higher than the maternal concentrations.